Philip T Went

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors
    Philip Went
    Institute of Pathology, University of Basel, Basel, Switzerland
    Am J Surg Pathol 29:83-8. 2005
  2. ncbi Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis
    Ellen C Obermann
    Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany
    BMC Cancer 5:162. 2005
  3. ncbi Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
    P Went
    Institute of Pathology, University Hospital Basel, Schonbeinstrasse 40, 4003 Basel, Switzerland
    Br J Cancer 94:128-35. 2006
  4. ncbi Plasma cell quantification in bone marrow by computer-assisted image analysis
    P Went
    Institute for Pathology, University of Basel, University Hospital, Schonbeinstrasse 40, 4031 Basel, Switzerland
    Histol Histopathol 21:951-6. 2006
  5. ncbi Abundant expression of AMACR in many distinct tumour types
    Philip T Went
    Institutes for Pathology, University of Basel, Switzerland
    Pathology 38:426-32. 2006
  6. ncbi Rare expression of BSAP (PAX-5) in mature T-cell lymphomas
    Alexandar S Tzankov
    Institute of Pathology and Bone Tumor Reference Center, University Hospital Basel, Basel, Switzerland
    Mod Pathol 20:632-7. 2007

Detail Information

Publications6

  1. ncbi Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors
    Philip Went
    Institute of Pathology, University of Basel, Basel, Switzerland
    Am J Surg Pathol 29:83-8. 2005
    ..The data suggest EpCam as a potential therapeutic target in a subset of patients with RCC. In addition, expression patterns of EpCam could become a helpful tool in the discrimination of chromophobe RCC and oncocytoma...
  2. ncbi Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis
    Ellen C Obermann
    Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany
    BMC Cancer 5:162. 2005
    ....
  3. ncbi Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
    P Went
    Institute of Pathology, University Hospital Basel, Schonbeinstrasse 40, 4003 Basel, Switzerland
    Br J Cancer 94:128-35. 2006
    ....
  4. ncbi Plasma cell quantification in bone marrow by computer-assisted image analysis
    P Went
    Institute for Pathology, University of Basel, University Hospital, Schonbeinstrasse 40, 4031 Basel, Switzerland
    Histol Histopathol 21:951-6. 2006
    ..e. computer-assisted digital image analysis and conventional light-microscopic evaluation. The results were compared regarding inter-observer variation of the obtained results...
  5. ncbi Abundant expression of AMACR in many distinct tumour types
    Philip T Went
    Institutes for Pathology, University of Basel, Switzerland
    Pathology 38:426-32. 2006
    ..To extend this diagnostic utility to other neoplasias, we comprehensively surveyed AMACR expression in human tumours...
  6. ncbi Rare expression of BSAP (PAX-5) in mature T-cell lymphomas
    Alexandar S Tzankov
    Institute of Pathology and Bone Tumor Reference Center, University Hospital Basel, Basel, Switzerland
    Mod Pathol 20:632-7. 2007
    ..It is rarely expressed in peripheral T-cell lymphoma, thus its detection on lymphoid malignancies cannot be considered definitively lineage specific...